Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Managing Michigan Auto No-Fault Claims with Confidence
Learn how Enlyte helps Michigan auto insurers manage no-fault claims with integrated utilization review, bill review, and field case management.
How Top Claims Teams Catch Risk Before Costs Escalate
In this podcast Rebecca Morgan, Vice President, Product Management, and Jim Harris, Vice President, Analytics & Reporting, share how leading organizations are transforming raw claim data into actionable intelligence that prevents delays and controls spend.
IAIABC Member Spotlight: Tom Kerr
In this IAIABC Member Spotlight, Tom Kerr of Enlyte shares how the company is advancing workers’ compensation through innovation, data-driven care, and a focus on better outcomes for injured workers.
Guidewire Connections 2025
Please join us at Guidewire Connections taking place October 27-30, 2025 at the Fontainebleau Las Vegas in Las Vegas, NV.
2025 AASCIF Annual Conference
Enlyte to Sponsor 2025 AASCIF Annual Conference in New OrleansEnlyte is proud to announce ou
Supporting Safer, Smarter Workplaces with Physical Demands Analysis
Learn how Genex’s Physical Demands Analysis helps employers understand job-specific physical requirements to support return-to-work, injury prevention, and ADA compliance.